Sequential CRISPR-Based Screens Identify LITAF and CDIP1 as the Bacillus cereus Hemolysin BL Toxin Host Receptors

Jie Liu1, Zehua Zuo2, Inka Sastalla3

  • 1Aging Institute of University of Pittsburgh and University of Pittsburgh Medical Center, Pittsburgh, PA 15219, USA; Division of Cardiology, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA 15219, USA.

Cell Host & Microbe
|June 17, 2020
PubMed

Insights

Researchers identified host factors for the potent Bacillus cereus toxin, hemolysin BL (HBL). Genome-wide screens revealed LPS-induced TNF-α factor (LITAF) and CDIP1 as HBL receptors, leading to resistant mice.

Area of Science:

  • Microbiology
  • Immunology
  • Genetics

Background:

  • Bacterial toxins cause significant human disease, but their mechanisms and host interactions are often unknown.
  • Hemolysin BL (HBL), a potent toxin from Bacillus cereus, has an uncharacterized mechanism of action and host factor requirements.
  • Understanding toxin-host interactions is crucial for developing targeted therapeutics.

Purpose of the Study:

  • To identify host factors essential for hemolysin BL (HBL) toxin activity using unbiased screening.
  • To elucidate the specific host receptors mediating HBL's cellular effects.
  • To validate the identified host factors in a preclinical model.

Main Methods:

  • Genome-wide CRISPR-Cas9 knockout screens were employed to identify host genes involved in HBL toxicity.
  • Iterative screening was used, first in wild-type cells and then in cells deficient for the initially identified receptor.
  • LITAF-deficient mice were generated to assess in vivo resistance to HBL.

Main Results:

  • LPS-induced TNF-α factor (LITAF) was identified as the primary receptor for HBL.
  • A subsequent screen identified CDIP1 as a secondary, alternative receptor for HBL.
  • LITAF-deficient mice demonstrated significant resistance to lethal HBL challenge, validating LITAF's role.

Conclusions:

  • LITAF and CDIP1 are critical host receptors for the Bacillus cereus toxin HBL.
  • Iterative genome-wide CRISPR screens provide a powerful platform for discovering host factors exploited by bacterial toxins.
  • This research opens avenues for therapeutic strategies targeting HBL-mediated pathogenesis.